Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Updated clinical data and biomarker analyses from the phase 1 study of DR-01, a non-fucosylated anti-CD94 antibody in patients with relapsed/refractory cytotoxic lymphomas
Updated clinical data and biomarker analyses from the phase 1 study of DR-01, a non-fucosylated anti-CD94 antibody in patients with relapsed/refractory cytotoxic lymphomas Horwitz, S., Zain, J., Querfeld, C., Kim, Y., Khodadoust, M., Andali, T., Kim, W., Poh, C., Yannakou, C., Reneau, J., Brammer, J., Pellegrini, C., Zinzani, P., Akilov, O., Marchi, E., Kwong, Y., Lee, J., Koh, Y., Reed, J., Dilley, K., Hong, W., Shi, R., Richardson, J., Tomasevic, N., Prince, M., Iyer, S. ELSEVIER. 2025View details for DOI 10.1182/blood-2025-3646
View details for Web of Science ID 001660685700046